Health Cor Management, L.P. Arcus Biosciences, Inc. Transaction History

Health Cor Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$31.38 - $48.47 $2.2 Million - $3.4 Million	-70,050 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.93 - $37.68 $1.89 Million - $2.64 Million	70,050 New	70,050 $2.44 Million
Q2 2021 Aug 16, 2021	SELL	$22.75 - $35.77 $12.2 Million - $19.2 Million	-536,970 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$26.16 - $41.39 $14 Million - $22.2 Million	536,970 New	536,970 $15.1 Million

186

49.2M

204K

149K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.1B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.